News & Events
PRESS RELEASE
Feb 4, 2025
Rejoni completes Patient enrollment
Rejoni completes patient enrollment in pivotal clinical study of a Novel Treatment for the Prevention of Intrauterine Adhesions, the Juveena® Hydrogel System.
Learn More
TRADESHOW
Nov 8-11, 2025
AAGL 2025 54th Annual Global Congress on MIGS
2025Vancouver Convention Centre
Vancouver, B.C. Canada
Learn More
The Juveena Hydrogel System in Pending FDA Approval. Not Available For Sale. Investigation Use Only.
Copyright © 2026 Rejoni. All Rights Reserved. These statements have not been evaluated by the Food and Drug Administration.
CAUTION – Limited by Federal (USA) Law to Investigational Use Only. REJ-MKT-0024-Rev. B
Privacy Statement